← Open Payments lookup

MELISSA MAINIER: Open Payments

NPI 1043833098 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,376 in 55 payments from 13 companies in 2025. Trend: 2023 $199 · 2024 $1,425 · 2025 $1,376

Food & beverage: $1,376
CompanyPaymentsAmount
Axsome Therapeutics, Inc.6$213
Supernus Pharmaceuticals, Inc.4$172
Neurocrine BioSciences, Inc.2$148
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$144
Tris Pharma Inc15$143
Lundbeck LLC7$135
Novo Nordisk Inc1$125
ABBVIE INC.4$80
Alkermes, Inc.2$78
Otsuka America Pharmaceutical, Inc.2$47

Products named: REXULTI, Qelbree, Auvelity, INGREZZA, CAPLYTA, Dyanavel XR, Wegovy, VRAYLAR.

Industry payments across MD — which companies pay providers there.